Nano-X Imaging (NNOX) Competitors $4.50 -0.05 (-1.10%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$4.50 0.00 (-0.11%) As of 08/14/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NNOX vs. MDXG, TNDM, PLSE, BLFS, IRMD, INMD, KMTS, SIBN, BBNX, and EMBCShould you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include MiMedx Group (MDXG), Tandem Diabetes Care (TNDM), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), iRadimed (IRMD), InMode (INMD), Kestra Medical Technologies (KMTS), SiBone (SIBN), Beta Bionics (BBNX), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. Nano-X Imaging vs. Its Competitors MiMedx Group Tandem Diabetes Care Pulse Biosciences BioLife Solutions iRadimed InMode Kestra Medical Technologies SiBone Beta Bionics Embecta MiMedx Group (NASDAQ:MDXG) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation. Which has more volatility & risk, MDXG or NNOX? MiMedx Group has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.95, indicating that its share price is 95% more volatile than the S&P 500. Is MDXG or NNOX more profitable? MiMedx Group has a net margin of 8.84% compared to Nano-X Imaging's net margin of -468.29%. MiMedx Group's return on equity of 23.03% beat Nano-X Imaging's return on equity.Company Net Margins Return on Equity Return on Assets MiMedx Group8.84% 23.03% 17.09% Nano-X Imaging -468.29%-32.09%-28.73% Does the media refer more to MDXG or NNOX? In the previous week, Nano-X Imaging had 10 more articles in the media than MiMedx Group. MarketBeat recorded 13 mentions for Nano-X Imaging and 3 mentions for MiMedx Group. MiMedx Group's average media sentiment score of 1.22 beat Nano-X Imaging's score of 0.09 indicating that MiMedx Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiMedx Group 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nano-X Imaging 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Which has preferable valuation and earnings, MDXG or NNOX? MiMedx Group has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMiMedx Group$348.88M3.03$42.42M$0.2134.05Nano-X Imaging$11.28M23.05-$53.52M-$0.90-5.00 Do institutionals and insiders believe in MDXG or NNOX? 79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 1.7% of MiMedx Group shares are owned by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts rate MDXG or NNOX? MiMedx Group presently has a consensus price target of $12.00, indicating a potential upside of 67.83%. Nano-X Imaging has a consensus price target of $8.50, indicating a potential upside of 88.89%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts plainly believe Nano-X Imaging is more favorable than MiMedx Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 SummaryMiMedx Group beats Nano-X Imaging on 9 of the 17 factors compared between the two stocks. Get Nano-X Imaging News Delivered to You Automatically Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNOX vs. The Competition Export to ExcelMetricNano-X ImagingTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$262.89M$2.66B$22.29B$9.84BDividend YieldN/A1.53%2.80%4.07%P/E Ratio-5.0022.8527.7625.74Price / Sales23.0536.8541.82115.83Price / CashN/A46.0127.3759.48Price / Book1.596.305.686.15Net Income-$53.52M$33.51M$198.41M$265.06M7 Day Performance-3.23%1.13%1.21%2.60%1 Month Performance-8.35%-2.31%-0.64%2.83%1 Year Performance-38.02%33.77%28.10%25.58% Nano-X Imaging Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNOXNano-X Imaging2.3074 of 5 stars$4.50-1.1%$8.50+88.9%-35.3%$262.89M$11.28M-5.00190News CoverageEarnings ReportAnalyst UpgradeMDXGMiMedx Group3.1401 of 5 stars$7.15-0.1%$12.00+67.8%+16.3%$1.06B$363.77M34.05870TNDMTandem Diabetes Care4.5764 of 5 stars$15.42+0.1%$32.71+112.2%-74.4%$1.03B$940.20M-5.552,650Trending NewsAnalyst DowngradeInsider TradeAnalyst RevisionPLSEPulse Biosciences3.8326 of 5 stars$15.07+2.2%$22.00+46.0%+2.9%$1.01B$700K0.00140News CoverageEarnings ReportBLFSBioLife Solutions2.3116 of 5 stars$20.89+0.4%$31.00+48.4%-2.2%$999.17M$82.25M-72.03440News CoverageEarnings ReportInsider TradeIRMDiRadimed4.517 of 5 stars$70.69+6.8%$72.00+1.9%+60.8%$899.18M$73.24M43.64110High Trading VolumeINMDInMode2.7881 of 5 stars$14.07+2.4%$18.04+28.2%-9.5%$889.37M$394.82M5.70480KMTSKestra Medical Technologies1.3645 of 5 stars$15.49+0.7%$27.33+76.5%N/A$795.41M$59.81M0.00300High Trading VolumeSIBNSiBone4.3712 of 5 stars$17.90+2.9%$22.50+25.7%+12.9%$762.81M$176.60M-27.97350Analyst ForecastInsider TradeBBNXBeta Bionics2.6568 of 5 stars$16.42+0.1%$22.56+37.4%N/A$713.78M$78.02M0.00294Positive NewsEMBCEmbecta4.7427 of 5 stars$9.79-1.7%$19.00+94.1%-6.0%$572.13M$1.12B10.882,100Positive NewsEarnings ReportGap Up Related Companies and Tools Related Companies MiMedx Group Competitors Tandem Diabetes Care Competitors Pulse Biosciences Competitors BioLife Solutions Competitors iRadimed Competitors InMode Competitors Kestra Medical Technologies Competitors SiBone Competitors Beta Bionics Competitors Embecta Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NNOX) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nano-X Imaging Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nano-X Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access